You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 135 No. 3, March 1981 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (59)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Altered Cellular Immune Functions in Patients With Down's Syndrome

Celsa A. Spina, PhD; Smith Diane, MT; Edward Korn, PhD; John L. Fahey, MD; Herbert J. Grossman, MD

Am J Dis Child. 1981;135(3):251-255.


Abstract



• Cell-associated immunocompetence was evaluated in 42 patients with Down's syndrome (DS) and compared with that of institutionalized patient control and normal control groups. B lymphocytes, as both percent of total lymphoid cells and absolute number, were markedly reduced in patients with DS. T-lymphocyte proliferative response to phytohemagglutinin mitogen also was significantly decreased. This altered response of the lymphocyte population was evident in both the presence and absence of accessory helper monocytes. Increased Fc receptor (FcR) cell activity, as measured by antibody-dependent cellular cytotoxicity was seen in both the patients with DS and the control patients. This probably resulted from common environmental factors such as exposure to infectious agents. No change was found in the WBC counts, percentages of lymphocytes and monocytes, percentages of T cells and FcR cells, or in the natural killer cell activity.

(Am J Dis Child 1981;135:251-255)



Author Affiliations



From the Clinical Immunology Research Laboratory, Department of Microbiology and Immunology, UCLA School of Medicine, Los Angeles (Drs Spina, Korn, and Fahey and Ms Smith), and Pacific State Hospital, Pomona, Calif (Dr Grossman).


Footnotes



Reprint requests to Department of Microbiology and Immunology, UCLA School of Medicine, Los Angeles, CA 90024 (Dr Spina).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Malignancy in Children with Trisomy 21
Rabin and Whitlock
The Oncologist 2009;14:164-173.
ABSTRACT | FULL TEXT  

Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study
Whitlock et al.
Blood 2005;106:4043-4049.
ABSTRACT | FULL TEXT  

Severe Mycoplasma Pneumonia in Young Children with Down Syndrome
Orlicek et al.
CLIN PEDIATR 1992;31:409-412.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.